Jenburkt Pharmaceuticals Ltd

JENBURPH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,520
Moderate RiskStock is 2.01x as volatile as Nifty
550.9515.95 (+2.98%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,520
Moderate RiskStock is 2.01x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
14.87
PB RatioPB Ratio
2.49
Dividend YieldDiv. Yield
1.91%
Sector PESector PE
38.70
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jenburkt Pharmaceuticals Limited is engaged in the manufacture of pharmaceutical formulations. The Company offers prescription and over-the-counter drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021118.06126.05123.11113.6017.2119.7914.8716.51
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Company Update 
Announced OnOct 27, 2021

JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Result 
Announced OnOct 26, 2021

JENBURKT PHARMACEUTICALS LTD. - 524731 - Standalone Unaudited Financial Results For Quarter And Half Year Ended On 30.09.2021 | Download

JENBURKT PHARMACEUTICALS LTD. - 524731 - Standalone Unaudited Financial Results For Quarter And Half Year Ended On 30.09.2021 | Download

Cash Dividend 
Ex. DateAug 30, 2021

Final • Div/Share: ₹ 10.2

See all events